CANCER GENETICS, INC Business Finance Contracts & Agreements

144 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Vyant Bio, Inc. Nonqualified Stock Option Grant Agreement under 2020 Stock Incentive Plan
Warrant Agreements
CANCER GENETICS, INC
Biotechnology
DE
2021
Vyant Bio, Inc. Common Stock Purchase Warrant Agreement with FOD Capital, LLC (March 2021)
Warrant Agreements
CANCER GENETICS, INC
Biotechnology
2021
Cancer Genetics, Inc. Placement Agent Common Stock Purchase Warrant Agreement with H.C. Wainwright & Co., LLC
Warrant Agreements
CANCER GENETICS, INC
Biotechnology
NY
2021
Cancer Genetics, Inc. Placement Agent Common Stock Purchase Warrant Agreement (February 2021)
Warrant Agreements
CANCER GENETICS, INC
Biotechnology
2021
Cancer Genetics, Inc. Series B Common Stock Purchase Warrant Agreement (February 2021)
Warrant Agreements
CANCER GENETICS, INC
Biotechnology
2021
Common Stock Purchase Warrant Agreement between Cancer Genetics, Inc. and Holder (November 2020)
Warrant Agreements
CANCER GENETICS, INC
Biotechnology
NY
2020
Note Purchase Agreement between Cancer Genetics, Inc. and Atlas Sciences, LLC dated October 21, 2019
Note Agreements
CANCER GENETICS, INC
Biotechnology
UT
2019
Promissory Note between Cancer Genetics, Inc. and Atlas Sciences, LLC dated October 21, 2019
Note Agreements
CANCER GENETICS, INC
Biotechnology
UT
2019
Subordinated Seller Promissory Note between Interpace BioPharma, Inc. and Cancer Genetics, Inc. dated July 15, 2019
Note Agreements
CANCER GENETICS, INC
Biotechnology
DE
2019
Cancer Genetics, Inc. Common Stock Purchase Warrant Agreement (2019–2024)
Warrant Agreements
CANCER GENETICS, INC
Biotechnology
NY
2019
Cancer Genetics, Inc. Common Stock Purchase Warrant Agreement
Warrant Agreements
CANCER GENETICS, INC
Biotechnology
NY
2019
Promissory Note between Cancer Genetics, Inc. and NovellusDX, Ltd. dated September 18, 2018
Note Agreements
CANCER GENETICS, INC
Biotechnology
2018
Credit Agreement between Cancer Genetics, Inc. and NovellusDX, Ltd. dated September 18, 2018
Credit Agreements
CANCER GENETICS, INC
Biotechnology
DE
2018
Description of Vyant Bio, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
CANCER GENETICS, INC
Biotechnology
DE
2023
Share Purchase Agreement between Vyant Bio, Inc. and Sabine Brandt as Trustee for the Brandt Family Trust
Purchase Agreements
CANCER GENETICS, INC
Biotechnology
2023
Share Purchase Agreement between vivoPharm Pty Ltd and Sabine Brandt as Trustee for the Brandt Family Trust
Purchase Agreements
CANCER GENETICS, INC
Biotechnology
2023
Equity Purchase Agreement among Reaction Biology Corporation, vivoPharm Pty, Ltd., Vyant Bio, Inc., and vivoPharm, LLC dated November 2, 2022
Purchase Agreements
CANCER GENETICS, INC
Biotechnology
DE
2022
Equity Distribution Agreement between Vyant Bio, Inc. and Canaccord Genuity LLC (April 8, 2022)
Equity Distribution Agreements
CANCER GENETICS, INC
Biotechnology
NY
2022
Registration Rights Agreement between Vyant Bio, Inc. and Lincoln Park Capital Fund, LLC (March 28, 2022)
Registration Rights Agreements
CANCER GENETICS, INC
Biotechnology
IL
2022
Purchase Agreement between Vyant Bio, Inc. and Lincoln Park Capital Fund, LLC dated March 28, 2022
Purchase Agreements
CANCER GENETICS, INC
Biotechnology
IL
2022
Description of Vyant Bio, Inc. Capital Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
CANCER GENETICS, INC
Biotechnology
DE
2022
Vyant Bio, Inc. Stock Unit Award Agreement with Awardee under 2021 Equity Incentive Plan
Equity Distribution Agreements
CANCER GENETICS, INC
Biotechnology
DE
2021
Description of Cancer Genetics, Inc. Securities Registered Under Section 12 of the Exchange Act
Registration Rights Agreements
CANCER GENETICS, INC
Biotechnology
DE
2021
Exclusive Placement Agent and Advisory Agreement between Cancer Genetics, Inc. and H.C. Wainwright & Co., LLC (September 18, 2020)
Equity Distribution Agreements
CANCER GENETICS, INC
Biotechnology
NY
2021
Securities Purchase Agreement between Cancer Genetics, Inc. and Purchasers (February 10, 2021)
Purchase Agreements
CANCER GENETICS, INC
Biotechnology
NY
2021
Registration Rights Agreement between Cancer Genetics, Inc. and Purchasers (January 28, 2021)
Registration Rights Agreements
CANCER GENETICS, INC
Biotechnology
2021
Securities Purchase Agreement between Cancer Genetics, Inc. and Purchasers (January 28, 2021)
Purchase Agreements
CANCER GENETICS, INC
Biotechnology
NY
2021
At the Market Offering Agreement between Cancer Genetics, Inc. and H.C. Wainwright & Co., LLC (December 2, 2020)
Equity Distribution Agreements
CANCER GENETICS, INC
Biotechnology
NY
2020
Amendment and Warrant Exchange Agreement between Cancer Genetics, Inc. and Warrant Holders (November 2020)
Modification Agreements
CANCER GENETICS, INC
Biotechnology
2020
Amended and Restated Underwriting Agreement between Cancer Genetics, Inc. and H.C. Wainwright & Co., LLC
Underwriting Agreements
CANCER GENETICS, INC
Biotechnology
NY
2020
Description of Cancer Genetics, Inc. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
CANCER GENETICS, INC
Biotechnology
DE
2020
Forbearance and Sixth Amendment to Amended and Restated Loan and Security Agreement between Silicon Valley Bank and Cancer Genetics, Inc. and Subsidiaries
Forbearance Agreements
CANCER GENETICS, INC
Biotechnology
DE
2019
Secured Creditor Asset Purchase Agreement among Interpace BioPharma, Inc., Partners for Growth IV, L.P., Cancer Genetics, Inc., and Interpace Diagnostics Group, Inc.
Purchase Agreements
CANCER GENETICS, INC
Biotechnology
DE
2019
Forbearance Agreement and Modification No. 4 to Loan and Security Agreement between Partners for Growth IV, L.P. and Cancer Genetics, Inc. and Affiliates
Forbearance Agreements
CANCER GENETICS, INC
Biotechnology
2019
Forbearance and Fifth Amendment to Amended and Restated Loan and Security Agreement between Silicon Valley Bank and Cancer Genetics, Inc. and Affiliates
Forbearance Agreements
CANCER GENETICS, INC
Biotechnology
DE
2019
Cancer Genetics, Inc. Underwriting Agreement with H.C. Wainwright & Co., LLC (January 9, 2019)
Underwriting Agreements
CANCER GENETICS, INC
Biotechnology
NY
2019
Registration Rights Agreement between Cancer Genetics, Inc. and NovellusDX, Ltd. dated September 18, 2018
Registration Rights Agreements
CANCER GENETICS, INC
Biotechnology
NY
2018
Third Waiver and Modification Agreement to Loan and Security Agreement between Partners for Growth IV, L.P. and Cancer Genetics, Inc. and Subsidiaries
Modification Agreements
CANCER GENETICS, INC
Biotechnology
CA
2018
Waiver and Third Amendment to Amended and Restated Loan and Security Agreement between Silicon Valley Bank and Cancer Genetics, Inc. and Affiliates
Modification Agreements
CANCER GENETICS, INC
Biotechnology
DE
2018
Securities Purchase Agreement between Cancer Genetics, Inc. and Iliad Research and Trading, L.P. (July 17, 2018)
Purchase Agreements
CANCER GENETICS, INC
Biotechnology
UT
2018